Analyst Ranking
Bottom 1%
#5267 out of 5290 analysts
Average Return
-10.01%
Win Rate
33%76 out of 229
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-20 -
2024-03-19
Buy
Anika Therapeutics IncANIK
+75.41%$8.26$14.48
2025-07-31 -
2026-06-05
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-28 -
2025-02-27
Buy
Anika Therapeutics IncANIK
+58.77%$9.12$14.48
2025-09-23 -
2026-06-05
Buy
Lifecore Biomedical IncLFCR
+54.15%$3.25$5.01
2023-03-21 -
2024-03-20
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Lemaitre Vascular IncLMAT
15Buy$120.00+27.01%Maintains
4 days ago
Orthofix Medical IncOFIX
8Buy$15.00+45.77%Maintains
17 days ago
Bioventus IncBVS
3Buy$14.00+54.87%Maintains
17 days ago
U S Physical Therapy IncUSPH
23Buy$90.00+41.84%Maintains
a month ago
Haemonetics CorpHAE
26Buy$89.00+24.86%Maintains
a month ago
Option Care Health IncOPCH
20Buy$32.00+56.02%Maintains
a month ago
Lifecore Biomedical IncLFCR
13Buy$6.00+6.57%Maintains
a month ago
Merit Medical Systems IncMMSI
27Buy$107.00+65.94%Maintains
2 months ago
Opko Health IncOPK
12Buy$1.50+4.17%Maintains
3 months ago
Dentsply Sirona IncXRAY
23Buy$17.00+70.00%Maintains
3 months ago
Anika Therapeutics IncANIK
17Buy$17.00+17.40%Maintains
3 months ago
Henry Schein IncHSIC
19Buy$97.00+25.24%Maintains
3 months ago
Verifyme IncVRME
11Buy$1.50+121.89%Maintains
5 months ago
Modivcare IncMODVQ
13Buy$6.00N/AMaintains
a year ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
5 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.